Drug Type Therapeutic vaccine, Dendritic cell vaccine |
Synonyms Ir-Vax therapy |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Ductal Carcinoma | Phase 2 | United States | - | |
| Glioblastoma | Phase 2 | United States | - | |
| Pancreatic Cancer | Phase 2 | United States | - | |
| Invasive Mammary Carcinoma | Phase 1 | United States | - | |
| Esophageal Carcinoma | Preclinical | United States | 07 Jun 2024 | |
| Melanoma | Preclinical | United States | 07 Jun 2024 | |
| Prostatic Cancer | Preclinical | United States | 07 Jun 2024 | |
| Stomach Cancer | Preclinical | United States | 07 Jun 2024 |





